Piperacillin / Tazobactam Intravenous (IV) Injection/Infusion bulk supplier for pharma manufacturers

Piperacillin / Tazobactam Intravenous (Iv) Injection/Infusion Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection/Infusion

Available Strengths: 2.25 g (2 g Piperacillin + 0.25 g Tazobactam); 3.375 g(3+3.75g); 4.5g(4+0.5g)

Reference Brands: Zosyn(US); Tazocin(EU)

Piperacillin + Tazobactam is a powerful IV antibiotic used to treat severe bacterial infections. Available in 2.25 g, 3.375 g, and 4.5 g strengths, it is marketed as Zosyn, Tazocin, and other generics. Pharma B2B platforms supply it extensively to hospitals and ICUs for critical care treatment.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Piperacillin + Tazobactam is a widely used broad-spectrum β-lactam/β-lactamase inhibitor combination antibiotic effective against a range of serious infections, including hospital-acquired pneumonia, intra-abdominal infections, and sepsis. It is administered intravenously and comes in 2.25 g, 3.375 g, and 4.5 g strengths, supplied as vials or ready-to-use infusions. In the US, it is marketed as Zosyn by Pfizer and through generics by Hikma, Fresenius, and Sandoz. In the EU, it’s sold as Tazocin and other branded generics. Piperacillin/Tazobactam is a key product on pharma B2B platforms, ensuring efficient procurement for hospitals, ICUs, and surgical departments.

Piperacillin / Tazobactam Intravenous (Iv) Injection/Infusion — third party manufacturing & bulk supply

Piperacillin / Tazobactam Intravenous (Iv) Injection/Infusion is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Piperacillin / Tazobactam Intravenous (Iv) Injection/Infusion is supplied as Intravenous (IV) Injection/Infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Piperacillin / Tazobactam Intravenous (Iv) Injection/Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Piperacillin / Tazobactam Intravenous (I... →

Back to Listing

Frequently Asked Questions

Piperacillin / Tazobactam is used to treat a wide range of serious bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and septicemia caused by susceptible organisms.

This medicine is made from two active components: Piperacillin, a broad-spectrum penicillin-class antibiotic, and Tazobactam, a beta-lactamase inhibitor that helps prevent bacterial resistance and enhances antibacterial activity.

Piperacillin / Tazobactam is commonly marketed under the trade name Zosyn and several other brand names depending on the region and manufacturer.

Piperacillin / Tazobactam is manufactured by multiple pharmaceutical companies worldwide, including Pfizer and various generic manufacturers.

The generic name is Piperacillin sodium and Tazobactam sodium.

Brand names include Zosyn and other regional brands marketed by different pharmaceutical companies.

Piperacillin / Tazobactam is manufactured in several countries including the USA, EU member states, India, and the UK by approved pharmaceutical manufacturers.